CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol. 2022;20(1):12-24.   Published online 2022 February 24    DOI: https://doi.org/10.22465/kjuo.2022.20.1.12

Excel Download

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
The Korean Journal of Urological Oncology. 2022;20(1):12-24   Crossref logo
Link1 Link2 Link3

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
Investigative and Clinical Urology. 2021;62:   Crossref logo
Link1 Link2 Link3

Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease
Bladder Cancer. 2015;1(2):105-116   Crossref logo
Link1

Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”
Urological Science. 2015;26(2):101-102   Crossref logo
Link1 Link2

Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer
Cancer. 2008;113(4):710-716   Crossref logo
Link1 Link2

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
Bladder Cancer. 2016;2(2):215-224   Crossref logo
Link1

The Challenge of Bacillus Calmette-Guérin Failure in Nonmuscle Invasive Bladder Cancer—What is the Next Step in Management?
Journal of Urology. 2013;190(3):832-833   Crossref logo
Link1 Link2 Link3

Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guérin Downregulation of Nonmuscle-invasive Bladder Cancer
Clinical Genitourinary Cancer. 2018;16(3):e587-e593   Crossref logo
Link1 Link2

Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle invasive Bladder Cancer: Con
European Urology Focus. 2021;   Crossref logo
Link1 Link2

Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin Treatment
Urology Practice. 2018;5(2):132-138   Crossref logo
Link1 Link2 Link3